Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuya Tsurutani

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Internal Medicine (Tokyo, Japan)|June 28, 2019
A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of HyperglycemiaNaoko Yamamoto, Yuya Tsurutani, Sho Katsuragawa, et al.
Biochemical and Biophysical Research Communications|March 2, 2011
The roles of transforming growth factor-β and Smad3 signaling in adipocyte differentiation and obesityYuya Tsurutani, Masaki Fujimoto, Minoru Takemoto, et al.
Journal of Medical Case Reports|May 22, 2021
Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reportsRei Hirose, Yuya Tsurutani, Chiho Sugisawa, et al.
JMIR Research Protocols|February 23, 2024
Efficacy of StepAdd, a Personalized mHealth Intervention Based on Social Cognitive Theory to Increase Physical Activity Among Patients With Type 2 Diabetes Mellitus: Protocol for a Randomized Controlled TrialKayo Waki, Yuya Tsurutani, Hironori Waki, et al.
Surgery|May 15, 2023
Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomasYusuke Goto, Takumi Kitamoto, Satoki Tanaka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2010
CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migrationTatsushi Shimoyama, Shûichi Hiraoka, Minoru Takemoto, et al.
Scientific Reports|May 17, 2016
A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammationRyoichi Ishibashi, Minoru Takemoto, Yoshihiro Akimoto, et al.
Experimental Diabetes Research|February 10, 2012
An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic miceMasaya Koshizaka, Minoru Takemoto, Seiya Sato, et al.
Plos One|April 28, 2022
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppressionHaremaru Kubo, Yuya Tsurutani, Kosuke Inoue, et al.
Scientific Reports|December 11, 2023
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center studyTakumi Kitamoto, Tsuyoshi Idé, Yuta Tezuka, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|June 28, 2019
A Patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of HyperglycemiaNaoko Yamamoto, Yuya Tsurutani, Sho Katsuragawa, et al.
Biochemical and Biophysical Research Communications|March 2, 2011
The roles of transforming growth factor-β and Smad3 signaling in adipocyte differentiation and obesityYuya Tsurutani, Masaki Fujimoto, Minoru Takemoto, et al.
Journal of Medical Case Reports|May 22, 2021
Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reportsRei Hirose, Yuya Tsurutani, Chiho Sugisawa, et al.
JMIR Research Protocols|February 23, 2024
Efficacy of StepAdd, a Personalized mHealth Intervention Based on Social Cognitive Theory to Increase Physical Activity Among Patients With Type 2 Diabetes Mellitus: Protocol for a Randomized Controlled TrialKayo Waki, Yuya Tsurutani, Hironori Waki, et al.
Surgery|May 15, 2023
Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomasYusuke Goto, Takumi Kitamoto, Satoki Tanaka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2010
CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migrationTatsushi Shimoyama, Shûichi Hiraoka, Minoru Takemoto, et al.
Scientific Reports|May 17, 2016
A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammationRyoichi Ishibashi, Minoru Takemoto, Yoshihiro Akimoto, et al.
Experimental Diabetes Research|February 10, 2012
An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic miceMasaya Koshizaka, Minoru Takemoto, Seiya Sato, et al.
Plos One|April 28, 2022
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppressionHaremaru Kubo, Yuya Tsurutani, Kosuke Inoue, et al.
Scientific Reports|December 11, 2023
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center studyTakumi Kitamoto, Tsuyoshi Idé, Yuta Tezuka, et al.
Pageof 6